# US 2008/0269487 A1 · 4-anilino quinazoline derivatives as antiproliferative agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0269487 A1
- Document ID: US20080269487A1
- Status: Published application
- Kind: A1
- Application number: 12/147,250
- Filed: 2008-06-26
- Published: 2008-10-30
- Earliest claimed: 2002-03-28
- Assignees: AstraZeneca AB
- Inventors: Robert Hugh Bradbury; Laurent Francois Andre Hennequin; Jason Grant Kettle
- Web page: https://patentgrep.com/patent/US20080269487A1

## CPC

- C07D 401/12: linked by a chain containing hetero atoms as chain links
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 13/08: of the prostate
- A61P 17/06: Antipsoriatics
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention concerns quinazoline derivatives of Formula (I) wherein each of Q1, Z, R1 and Q2 have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosine kinases.

## Claims

### Claim at position 1

1-22. (canceled)

### Claim 23

6-{[1-(carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline and/or a pharmaceutically acceptable salt thereof.
